Fulcrum Therapeutics Expects $240 Million Cash Position as of December 31, 2024
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) recently provided an update on its financial situation through an updated corporate presentation published on its website on January 13, 2025. While the comprehensive financial results for the fourth quarter and fiscal year ending December 31, 2024, are yet to be finalized, the company anticipates reporting approximately $240 million in […]
More Stories
Harbour Investments Inc. Sells 71 Shares of AppLovin Co. (NASDAQ:APP)
Harbour Investments Inc. lowered its stake in shares of AppLovin Co. (NASDAQ:APP – Free Report) by 45.8% in the fourth...
Signaturefd LLC Sells 4,522 Shares of Smurfit Westrock Ltd (NYSE:SW)
Signaturefd LLC lowered its stake in shares of Smurfit Westrock Ltd (NYSE:SW – Free Report) by 80.7% during the fourth...
JPMorgan Chase & Co. (NYSE:JPM) Shares Acquired by Parallel Advisors LLC
Parallel Advisors LLC lifted its position in JPMorgan Chase & Co. (NYSE:JPM) by 0.9% during the fourth quarter, according to...
Signaturefd LLC Has $18.21 Million Stock Position in JPMorgan Chase & Co. (NYSE:JPM)
Signaturefd LLC increased its stake in JPMorgan Chase & Co. (NYSE:JPM) by 2.8% in the 4th quarter, according to the...
Natixis Advisors LLC Has $1.91 Million Position in CAVA Group, Inc. (NYSE:CAVA)
Natixis Advisors LLC boosted its position in shares of CAVA Group, Inc. (NYSE:CAVA – Free Report) by 54.1% during the...
Cibc World Markets Corp Makes New $355,000 Investment in StepStone Group LP (NASDAQ:STEP)
Cibc World Markets Corp acquired a new stake in shares of StepStone Group LP (NASDAQ:STEP – Free Report) in the...